Clinical Trial Update: Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluating the safety and efficacy of a triple combination therapy in patients with glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Triple combination therapy

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2013-09-19